Role of the phosphatidylinositol-specific phospholipase C pathway in δ-opioid receptor-mediated antinociception in the mouse spinal cord

Neuroscience

Volumn 99, Issue 2, 2000, Pages 327-331

  Narita, M ^a,b   Ohsawa, M ^a   Mizoguchi, H ^a   Aoki, T ^b   Suzuki, T ^b   Tseng, L F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

d Ala2 deltorphin II; Inositol trisphosphate; Phosphoinositol hydrolysis; Protein kinase C

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DELTA OPIATE RECEPTOR; DELTORPHIN; KT 5720; NEOMYCIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C INHIBITOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MOUSE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS; ANIMALS; CARBAZOLES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTRENES; INDOLES; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MICE; MICE, INBRED ICR; NAPHTHALENES; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; PROTEIN KINASE C; PYRROLES; PYRROLIDINONES; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 0034638244     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00202-5     Document Type: Article

References (38)

1. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmac. exp. Ther. 72:1941;74-79.
2. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. natn. Acad. Sci. USA. 86:1989;5188-5192.
3. Evans C., Keith D., Morrison H., Magedzo K., Edwards R. Cloning of a delta receptor by functional expression. Science. 258:1992;1952-1955.
4. Huang L.-Y. M. (1995) Cellular mechanisms of excitatory and inhibitory actions of opioids. In The Pharmacology of Opioid Peptides (ed. Tseng L. F.), pp. 131-149. Harwood Academic, Switzerland.
5. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmac. 167:1980;313-316.
6. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252a compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. biophys. Res. Commun. 142:1987;436-440.
7. Kennedy E.D., Challiss R.A., Rangan C.I., Nahorski S.R. Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices. Biochem. J. 267:1990;781-786.
8. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc. natn. Acad. Sci. USA. 89:1992;12,048-12,052.
9. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. biophys. Res. Commun. 159:1989;548-553.
10. Mattia A., Farmer S.C., Takemori A.E., Sultana M., Portoghese P.S., Mosberg H.I., Bowen W.D., Porreca F. Spinal opioid delta antinociception in the mouse: modulation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmac. exp. Ther. 260:1992;518-525.
11. Miyamae T., Fukushima N., Misu Y., Ueda H. Opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes. Fedn Eur. biochem. Socs Lett. 333:1993;311-314.
12. Mizoguchi H., Narita M., Tseng L.F. Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming. Regul. Pept. 59:1995;255-259.
13. Murthy K.S., Makhlouf G.M. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Molec. Pharmac. 50:1996;870-877.
14. 2-opioid receptor agonist in the mouse spinal cord. Eur. J. Pharmac. 310:1996;R1-R3.
15. Narita M., Narita M., Mizoguchi H., Tseng L.F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouse. Eur. J. Pharmac. 280:1995;R1-R3.
16. Narita M., Tseng L.F. Stimulation of spinal δ-opioid receptors selectively enhances the attenuation of δ-opioid receptor mediated antinociception by antisense oligodeoxynucleotide in the mouse. Eur. J. Pharmac. 284:1995;185-189.
17. 2-opioid receptor agonist in the mouse spinal cord. Br. J. Pharmac. 120:1997;587-592.
18. Narita M., Mizoguchi H., Kampine J.P., Tseng L.F. Role of protein kinase C in desensitization of spinal δ-opioid-mediated antinociception in the mouse. Br. J. Pharmac. 118:1996;1829-1835.
19. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
20. Phillippe M. Neomycin inhibition of hormone-stimulated smooth muscle contractions in myometrial tissue. Biochem. biophys. Res. Commun. 205:1994;245-250.
21. Porreca F., Bilsky E. J. and Lai J. (1995) Pharmacological characterization of opioid δ and κ receptors. In The Pharmacology of Opioid Peptides (ed. Tseng L. F.), pp. 219-248. Harwood Academic, Switzerland.
22. Raynor K., Kong H., Heerding J., Hines J., Benovic J., Reisine T. Differential agonist modulation of the cloned opioid receptors reveals distinct cellular mechanisms of receptor regulation. Regul. Pept. 54:1994;239-240.
23. Rodríguez-Díaz M., Garzón J., Sánchez-Blázquez P. The delta2-opioid receptor subtype stimulates phosphoinositide metabolism in mouse periaqueductal gray matter. Life Sci. 62:1998;PL253-PL258.
24. Sánchez-Blázquez P., Garzón J. Delta opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J. Pharmac. exp. Ther. 285:1998;820-827.
25. Sánchez-Blázquez P., Rodríguez-Díaz M, Frejo M.T., Garzón J. Stimulation of μ- and δ-opioid receptors enhances phosphoinositide metabolism in mouse spinal cord: evidence for subtypes of δ-receptors. Eur. J. Neurosci. 11:1999;2059-2064.
26. 2+ from intracellular stores, in undifferentiated NG108-15 cells. J. Neurochem. 66:1996;1462-1467.
27. Smith F.L., Lohmann A.B., Dewey W.L. Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br. J. Pharmac. 128:1999;220-226.
28. Standifer K.M., Chien C.-C., Wahlestedt C., Brown G.P., Pasternak G.W. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron. 12:1994;805-810.
29. Tallarida R.J., Murray R.B. Manual of Pharmacological Calculation with Computer Programs. 1987;Springer, New York.
30. Tseng L.F., Collins K.A. Spinal involvement of both dynorphin A and met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. J. Pharmac. exp. Ther. 266:1993;1430-1438.
31. Tseng L.F., Collins K.A. Antisense oligodeoxynucleotide to a δ-opioid receptor given intrathecally blocks i.c.v. administered β-endorphin-induced antinociception in the mouse. Life Sci. 55:1994;PL127-PL131.
32. Tseng L.F., Collins K.A., Kampine J.P. Antisense oligodeoxynucleotide to δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmac. 258:1994;R1-R3.
33. 1-opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse. Life Sci. 52:1994;PL211-PL215.
34. 2]deltorphin II-induced antinociception in mice receiving spinally with a δ-opioid antisense oligodeoxynucleotide. Eur. J. Pharmac. 287:1995;169-172.
35. Tsu R.C., Chan J.C.S., Wong T.H. Regulation of multiple effectors by the cloned delta-opioid receptor stimulation of phospholipase C and type II adenylyl cyclase. J. Neurochem. 64:1995;2700-2707.
36. i1-phospholipase C activation in Xenopus oocytes. J. Neurosci. 15:1995;7485-7499.
37. Wakdo G.L., Northup J., Perkins J.P., Harden T.K. Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization. J. biol. Chem. 258:1983;13900-13908.
38. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J. biol. Chem. 267:1992;13830-13835.